Phase 1b study of carfilzomib with induction chemotherapy in pediatric relapsed/refractory acute lymphoblastic leukemia.
Michael J BurkeDavid S ZieglerFrancisco J Bautista SirventAndishe AttarbaschiLia GoreFranco LocatelliMaureen M O'BrienMelinda G PaulyWilliam N KormanyShengqi TianChristopher L MorrisAndre BaruchelPublished in: Pediatric blood & cancer (2022)
These data support the use of carfilzomib in pediatric patients with relapsed and/or refractory ALL.